Ir al contenido

Our Network

Cevaxin

Panama City, Panama

60+ studies, 20,000+ participants; strong invaccines, RSV, HIV

Specialties

Vaccines, infectious diseases, respiratory, HIV, HPV, pneumococcus, RSV

Key infrastructure:

  • Medical offices, in-house pharmacy, and laboratory
  • Monitoring room and informed consent facilities.
  • Real-time management platform

Completed studies

  • 60+clinical trials
  • 20,000+participants
  • Pediatric, adult, and pregnant populations
  • Contributions to 10+vaccines now approved
Visit Site

CEIP

Cali, Colombia

50+ studies, 28,000+ participants; maternal-child health, community trials

Specialties

Vaccines, infectious diseases, maternal-child health, community-based studies

Key infrastructure:

  • 14 consultation rooms, pharmacy, laboratory, and call center
  • Resuscitation room and auditorium
  • 85 °C freezers, cold storage units, and redundant connectivity systems

Completed studies

  • 50+ clinical trials
  • 28,000+ enrolled participants
  • Contributions to 15 approved vaccines
Visit Site

CECLISA

Guatemala City, Guatemala

20+ studies; pediatrics, gastroenterology, advanced lab capacity

Specialties

Vaccines, pediatrics, respiratory diseases, gastroenterology

Key infrastructure:

  • Pediatric and adult consultation rooms
  • Laboratory with sample processing and PBMC capabilities
  • Procedure and observation rooms
  • 70 °C freezers and validated cold chain

Completed studies

  • 20+ clinical trials
  • Participation in phase II and III studies, including pediatric and COVID-19 vaccine trials
Visit Site

Policlínico Social del Norte

Bogotá, Colombia

6+ studies; gastro and respiratory; fast-track enrollment and strong infrastructure

Specialties

Vaccines, gastroenterology, respiratory health

Key infrastructure:

  • Private IPS with over 30 years of clinical experience
  • Research center approved by INVIMA
  • Electronic medical records and fast-track enrollment capability

Completed studies

  • 6+ clinical trials since 2021
  • Record-setting enrollment in COVID-19 and RSV studies
Visit Site

Meet Our Experts

Dr. Rodrigo DeAntonio
Dr. Rodrigo DeAntonio

Scientific Director at Cevaxin; leader in public health and vaccine research.

  • MD, epidemiologist, Master in Health Economics, Doctor in Public Health, and Executive and Scientific Director at Cevaxin in Panama.
  • Leads clinical and epidemiological research on vaccine-preventable diseases.
  • Studies include rotavirus, pneumococcus, meningococcus, HPV, pertussis, hepatitis, RSV, influenza, chickenpox, norovirus, dengue, and COVID-19.
Dr. Xavier Saez Llorens
Dr. Xavier Saez Llorens

Pediatric infectious disease expert; research director at Hospital del Niño.

  • Medical degree from the University of Panama, with postdoctoral training in Pediatrics (Panama) and Infectious Diseases (UT Southwestern, USA).
  • Professor of Pediatrics, Chief of Infectious Diseases, and Director of Clinical Research at Hospital del Niño Dr. José Renán Esquivel.
  • Distinguished investigator (Senacyt, Cevaxin), advisor for Panama’s COVID-19 vaccination efforts, and member of various ethics and scientific committees.
Dr. Eduardo Lopez-Medina
Dr. Eduardo Lopez-Medina

Director at CEIP; specialist in pediatric vaccines and global research.

  • Physician trained at Universidad del Valle (Colombia), pediatric residency at Miami Children’s Hospital, and fellowship at University of Texas.
  • Master’s in Epidemiology (University of London) and clinical research program at Harvard.
  • Research on vaccine-preventable diseases and infections in immunocompromised children; widely published in scientific journals.
Dr. Mario Melgar
Dr. Mario Melgar

Director at CECLISA; leads pediatric oncology and infectious disease studies.

  • Pediatric infectious diseases specialist trained at Federico Gómez Children’s Hospital (Mexico).
  • Heads Pediatric Infectious Diseases at Roosevelt Hospital and Guatemala’s National Pediatric Oncology Unit.
  • Director of CECLISA, running Phase I–III clinical trials in vaccines, rheumatology, oncology, and more.
Dr. Gabrielle Britton
Dr. Gabrielle Britton

Executive Director of Cevaxin Neuroscientist specializing in aging, mental health, and neurodegeneration.

PhD in Psychology and Neuroscience. She has coordinated projects funded by SENACYT, EULAC, and BID, focusing on brain health and aging in adults.​ Creator of the longitudinal study Panama Aging Research Initiative – Health Disparities (PARI-HD) at INDICASAT AIP Research field: Alzheimer's Cognitive impairment Mental health in adults COVID-19 and cognitive function Health disparities and aging

Dr. Pío López
Dr. Pío López

General Director of the Center for Studies in Pediatric Infectious Diseases (CEIP)

  • Infectious disease specialist and pediatrician. - General Director of the Center for Studies in Pediatric Infectious Diseases (CEIP), Cali, Colombia.
  • Former President of the Colombian Association of Infectious Diseases (ACIN) for the terms 2015–2017 and 2017–2019.
  • Former President of the Latin American Society for Pediatric Infectious Diseases (SLIPE) from 2019 to 2021.